Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...
Үндсэн зохиолчид: | Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
1986
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
-н: Turpie AGG
Хэвлэсэн: (2014-03-01) -
A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
-н: Andrei Viktorovich Fonyakin, зэрэг
Хэвлэсэн: (2012-09-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
-н: Paula Tiili, зэрэг
Хэвлэсэн: (2021-01-01) -
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
-н: Tommaso Sacquegna, зэрэг
Хэвлэсэн: (2015-12-01) -
Prevalence of oral anticoagulation in atrial fibrillation
-н: Eduardo Bartholomay, зэрэг
Хэвлэсэн: (2014-09-01)